Effect of Honey and Dextromethorphan on Nocturnal Cough and Sleep Quality for Coughing Children and Their Parents
Cough is the most common reason for an acute care doctor’s visit in the United States. Cough can affect sleep for both coughing children and their parents. The American Academy of Pediatrics does not endorse the use of dextromethorphan (DM), the most common over-the-counter (OTC) cough medication because of a lack of efficacy data and some potential for toxicity, particularly when taken in excess. In fact, DM has previously been shown to be no better than a placebo for cough in children. Therefore, alternative, therapeutic agents are needed. Honey anecdotally provides relief for symptoms due to upper respiratory tract infection (URI). This study seeks to use a survey to evaluate whether a single dose of honey and/or DM is better than no treatment at all for controlling nocturnal cough in children with URI and the effect of the treatments on sleep quality for coughing children and their parents. A single dose of honey or DM will be superior to no treatment for control of nocturnal cough due to upper URI as rated by both parents and children and will improve the sleep quality for those children and parents. Compared to DM, honey will be superior for controlling nocturnal cough due to upper URI (also based on child and parental report).
Description
Cough is one of the most common reasons for a doctor’s visit in the United States and may be the most bothersome symptom for children with colds. It is particularly annoying at night because it can interrupt sleep for both coughing children and their parents. Dextromethorphan (DM), the most common over-the-counter (OTC) “cough medication,” may not be as helpful for these symptoms as previously believed. Because of this, treatments are needed to better reduce the symptoms from a cold. Honey is a naturally occurring substance that may provide relief for cold symptoms. Children are being offered the opportunity to take part in this research because they have been diagnosed with a cold and have had difficulty sleeping due to their cough.
The purpose of this research is to use a survey to see if a single dose of honey or DM is better than no treatment at all for controlling nighttime cough in children, ages 2 to less than 18 years with a cold and if the medicine or honey helps the quality of sleep for the coughing children and their parents. DM has been approved by the Food and Drug Administration (FDA) and is available over the counter. The form of honey used in this study may also be purchased without a doctor’s prescription.
About 125 male and female children from 2 to less than 18 years old will take part in this study at the Hershey Medical Center.
Status: Completed (Phase 1). Started on September 1st, 2005. Ended on December 1st, 2006.
Enrollment: 105 subjects
Study Type: Interventional
Study Design:
- Treatment
- Randomized
- Double-Blind
- Active Control
- Factorial Assignment
- Efficacy Study
Conditions:
Interventions:
- Drug: Dextromethorphan
- Drug: Buckwheat Honey
Eligibility
Inclusion Criteria:
Ages 2 to <18 years
Cough due to upper respiratory tract infection (URI), as determined by physical examination
Sleep difficulty on the preceding night attributed to frequent cough
Ability to swallow liquids
Willingness of the child’s guardian to participate in a survey
Exclusion Criteria:
Signs/symptoms of more serious/treatable disease
Itchy, watery eyes
Frequent sneezing, tachypnea (respiratory rate >95th percentile) or labored breathing; symptoms for 8 or more days.
History of asthma in the past 2 years
Chronic lung disease, or seizure disorder
Allergic reaction to honey or DM
Selective serotonin reuptake inhibitors (SSRIs) or anti-malarial drugs
Diabetes mellitus or signs/symptoms of insulin resistance
- Gender
Both
- Mininum Age
2 Years
- Maximum Age
18 Years
- Healthy Volunteers
No
Resources
Source: Penn State University
Authority: United States: Institutional Review Board
Locations
-
Penn State Milton S. Hershey Medical Center
Hershey
Pennsylvania
17545
United States
Officials
Ian M Paul, MD, MSc (Principal Investigator, Penn State College of Medicine)
Sponsors
Penn State University (Lead Sponsor)
National Honey Board (Collaborator)
References
None.
Links
- Date Verified
- November 1st, 2007
- First Received
- November 30th, 2007
- Last Changed
- November 30th, 2007
Information obtained from ClinicalTrials.gov on July 15, 2008. Link to the current ClinicalTrials.gov record.
All data in the Healia Clinical Trials Information Database and content displayed by the Healia Clinical Trials Search Engine are licensed from the National Institutes of Health (National Library of Medicine), which collects and maintains the data.
The Healia Clinical Trials Search Engine searches the data set at clinicaltrials.gov, providing up-to-date information about current clinical trials. In the Healia Clinical Trials Database you can find information on new experimental drugs, medical devices, and other types of treatments for all types of diseases. Each clinical trial description includes information about the phase of the trial (phase I, phase II, or phase III), the trial’s methods, such as whether it is a randomized, placebo controlled, double blind study, and the status of the trial including whether or not the trial is currently enrolling new participants.